1. Home
  2. Labeler Index
  3. Aft Pharmaceuticals Ltd
  4. 72260-129
  5. NDC Package Code: 72260-129-01 Combogesic

NDC Package 72260-129-01 Combogesic

Acetaminophen And Ibuprofen Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
72260-129-01
Package Description:
250 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product Code:
72260-129
Proprietary Name:
Combogesic
Non-Proprietary Name:
Acetaminophen And Ibuprofen
Substance Name:
Acetaminophen; Ibuprofen
Usage Information:
COMBOGESIC and is indicated in adults for the short-term management of mild to moderate acute pain.
11-Digit NDC Billing Format:
72260012901
NDC to RxNorm Crosswalk:
  • RxCUI: 2675760 - acetaminophen 325 MG / ibuprofen 97.5 MG Oral Tablet
  • RxCUI: 2675760 - APAP 325 MG / ibuprofen 97.5 MG Oral Tablet
  • RxCUI: 2675765 - combogesic 325 MG / 97.5 MG Oral Tablet
  • RxCUI: 2675765 - acetaminophen 325 MG / ibuprofen 97.5 MG Oral Tablet [Combogesic]
  • RxCUI: 2675765 - APAP 325 MG / ibuprofen 97.5 MG Oral Tablet [Combogesic]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Aft Pharmaceuticals Ltd
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ACETAMINOPHEN 325 mg/1
  • IBUPROFEN 97.5 mg/1
    • Pharmacologic Class(es):
  • Anti-Inflammatory Agents, Non-Steroidal - [CS]
  • Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
  • Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA209471
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    03-01-2024
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 72260-129-01?

    The NDC Packaged Code 72260-129-01 is assigned to a package of 250 tablet, film coated in 1 bottle, plastic of Combogesic, a human prescription drug labeled by Aft Pharmaceuticals Ltd. The product's dosage form is tablet, film coated and is administered via oral form.

    Is NDC 72260-129 included in the NDC Directory?

    Yes, Combogesic with product code 72260-129 is active and included in the NDC Directory. The product was first marketed by Aft Pharmaceuticals Ltd on March 01, 2024 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 72260-129-01?

    The 11-digit format is 72260012901. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-272260-129-015-4-272260-0129-01